How does Trendshare evaluate INFU as a worked example?

This example shows how we apply the Trendshare checklist to INFU: earnings power, cash generation, valuation, and margin of safety. We look at business quality, free cash flow trends, price to earnings, and whether there is a reasonable margin of safety at the current price of 14.76.

InfuSystem Holdings Stock Price and Value Analysis

InfuSystem Holdings (NYSE American:INFU) in our automated value investing analysis, with the cash flow history and price comparison below.

Key Facts

Ticker: INFU (NYSE American)
Current price: $14.76
Sector: Healthcare
Industry: Medical Devices

Advertisement helps keep Trendshare free for most readers.

Hold-time calculator

Estimate how long you need to hold InfuSystem Holdings to reach your target.

Target type Target price Target total return %

Current price

Expected annual return (compound annual growth rate, CAGR)

Margin of safety (%)

Target price (Trendshare FV)

Include dividend yield
N/A

INFU Free Cash Flow Trend

Free Cash Flow trendline for INFU — Free Cash Flow trendline for InfuSystem Holdings

CSV

Based on historical returns, we believe that InfuSystem Holdings can grow its free cash at a rate of about 7%. That's positive!

Advantages	Disadvantages	Neutral
This company is making money at a decent rate.	This stock looks overpriced. This company is less known than others. This company has wild ups and downs.	This company pays no dividend.

Inside the INFU Numbers

	INFU Price (InfuSystem Holdings stock price per share)	$14.76
× Present Value/Intrinsic Valuation The intrinsic value of a company is how much cash it can generate over its lifespan. If a business lasts for ten years and produces a million dollars of free cash profit every year, its intrinsic value is ten million dollars. The present value of an investment is the price you must pay right now to earn that intrinsic value in however many years you want to wait. This of course depends on the rate of return you want for your investment. You can't predict what a company will make in the future with perfect accuracy, but a company with a history of increasing its free cash flow every year is likely to do so over time. By projecting free cash flow into the future, you can calculate a fair price for the stock right now. While most stocks are priced fairly, sometimes they go on sale. This calculation will help you decide that. You still have to figure out if it's a good investment, but bargains exist. Close ^[?]	INFU Fair Price (based on intrinsic value)	$2.86
× Safety Margin Price The safety margin of a stock helps you avoid risk. Why? Because the discounted free cash flow analysis relies on estimates, discounting the fair price by a further safety margin gives you some wiggle room to be wrong about those estimates. Established companies with stable free cash flow growth need a small safety margin. Smaller and newer and riskier companies need a larger safety margin. A company with a lot of debt needs a larger safety margin and a company with a lot of equity needs less. By investing in multiple companies and keeping a sensible safety margin, you can be pleasantly surprised by great companies outperforming your expectations and minimize the possibility of stagnation (or even loss) by companies which underperform. Close ^[?]	INFU Safety Price (based on a variable margin of safety)	$1.72
	Try your own return The fair price above uses a 10.1% discount rate, the long-run US stock return (10.1% geometric, 1926 to 2025, from Bessembinder's working paper, updated 2026-11-09), and 2.5% terminal growth. A higher rate suits a higher return target and gives a lower value. Discount rate (%) Terminal growth (%) Value per share:
× PE Ratio Versus Sector The PE ratio measures the reported earnings of a company to its current stock price. While earnings are easy to manipulate on the balance sheet, this ratio gives you a sense of what buyers are willing to pay for the stock—what they believe it will do in the future. Comparing a stock's PE to the average PE of companies in its industry gives you a sense of market sentiment about the stock and how well it fares financially. It's not the only number, nor the most important, but comparing similar companies is valuable. A ratio far above or below that of its peers is significant. Industries are more specific than sectors, so companies within most industries are more similar than are companies within an industry. Be aware that the size and customers of companies are important to their prospects. Close ^[?]	PE Ratio versus Sector	65% higher than other Healthcare stocks
× PE Ratio Versus Industry The PE ratio measures the reported earnings of a company to its current stock price. While earnings are easy to manipulate on the balance sheet, this ratio gives you a sense of what buyers are willing to pay for the stock—what they believe it will do in the future. Comparing a stock's PE to the average PE of companies in its sector gives you a sense of market sentiment about the stock and how well it fares financially. It's not the only number, nor the most important, but comparing similar companies is valuable. A ratio far above or below that of its peers is significant. Be aware that sectors are very broad, with many types of companies in the same sector. Close ^[?]	PE Ratio versus Industry	53% lower than other Medical Devices stocks
× Free Cash Flow Jitter The free cash flow jitter of a stock measures how much the company's free cash flow varies from its historical trend, on average. While it's always nice to make more money than you expected, a company with predictable free cash flow is stable and good. A company with wild swings in its free cash flow warrants further research. In general, the lower this number, the better. Close ^[?]	Free Cash Flow Jitter	50%

Insider Activity Summary

No open-market insider buys or sells are recorded for the last 12 months.

This stock has short interest! This means that people have shorted it.

Why does that matter? They've made a bet that price will decrease from where they bought it. Maybe there are financial problems, or maybe there's a value play.

As of the latest analysis, there are 683,086 shares shorted. With 18,910,010 shares available for purchase and an average trading volume over the past 10 trading days of 184,350, it would take at least 3.7 days for all of the short holders to cover their shorts.

Estimate Intrinsic Value (DCF)

Project future free cash flow and discount it back to today to compare market price vs intrinsic value. See how compound returns work over time.

📊 Intrinsic Value Calculator (DCF Method)

Calculate the present value of future cash flows to determine stock intrinsic value.

Annual Free Cash Flow ($):

Current or most recent year free cash flow (operating cash - capex)

Expected Annual Growth Rate (%):

Conservative estimate (3-7% for mature companies, 10-20% for growth)

Discount Rate (%):

Required rate of return (8-10% stable, 12-15% growth, 15%+ speculative)

Projection Period (Years):

Longer projections are less certain but may reveal more value

Terminal Value Multiple:

Exit multiple for terminal value (10-15x typical for mature companies)

Calculation Results

Total Intrinsic Value:

Discounted Cash Flows:

Terminal Value (PV):

Year	Future CF	Present Value

How to use this result: Compare the intrinsic value to the current stock price. If intrinsic value is significantly higher than market price (30-50% margin of safety), the stock may be undervalued. Remember, these are estimates based on your assumptions.

Learn to Evaluate INFU

Learn how to evaluate stocks, understand expected returns, and build a value investing strategy.

See How Returns Compound →

Free Cash Flow by Fiscal Year

Each year names the SEC filer that reported it, so a change of filer shows up here.

Fiscal year	SEC filer (CIK)	Free cash flow (USD millions)
2009	1337013	5.1
2010	1337013	7.3
2011	1337013	1.7
2012	1337013	-0.0
2013	1337013	1.9
2014	1337013	1.8
2015	1337013	1.2
2016	1337013	2.7
2017	1337013	3.3
2018	1337013	6.6
2019	1337013	9.3
2020	1337013	16.3
2021	1337013	15.2
2022	1337013	14.7
2023	1337013	9.8
2024	1337013	19.4
2025	1337013	23.5

Download the yearly data as CSV.

Price Versus Our Estimated Value

Only 16 of the 17 fiscal years under InfuSystem Holdings's current filer show positive free cash flow.

The latest three years average $17.6 million in free cash flow against $4.7 million for the earliest three, which is a sharp rise.

Free cash flow is volatile from year to year, with a variability measure of 50%.

Our fair value estimate for InfuSystem Holdings is $2.86, below its current price of $14.76.

Dividends are not in our data for InfuSystem Holdings.

These numbers change when new filings or prices arrive, so treat this page as a snapshot and check the company's own filings.

Compared With Its Sector and Industry

Its trailing P/E ratio is 65% above the average for stocks in the Healthcare sector.

Its trailing P/E ratio is 53% below the average for stocks in the Medical Devices industry.

A P/E ratio depends on trailing earnings, which one-time items can distort, so a lower P/E is not by itself evidence of value.

SEC Filer History

Every fiscal year on this page is reported by one SEC filer, CIK 1337013.

Each figure on this page comes from that filer.

Risks to This Analysis

Free cash flow was negative in 1 of the 17 years we have.
Free cash flow is volatile from year to year, so the estimates depend heavily on which years are included.
These figures are automated calculations from SEC filings and the recent price. They may contain errors, and they do not reflect lawsuits, management changes, or other events the filings do not show.

Advertisement supports free stock analysis content.

Questions to Answer Before You Invest in INFU

Does InfuSystem Holdings have a coherent story? Does it have a plan to continue to make money? Is it worth your time? Only you can decide where to go from here. Our investment guide helps you ask the right questions, including how to buy stocks. Use these research links for more information.

Step 1 — Snapshot
- Price: 14.76
- Market cap: $296M
- EPS: 0.44
Step 2 — Valuation checks
- P/E: 33.545
- FCF yield: —
- Date checked: Nov 12, 2026
Step 3 — Margin of safety
- Compare price to fair value and safety price.
- Look for durable cash generation and reasonable leverage.
- Decide if it passes your personal checklist.